Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Reactivation of unstable angina after the discontinuation of heparin.

Théroux P, Waters D, Lam J, Juneau M, McCans J.

N Engl J Med. 1992 Jul 16;327(3):141-5.

2.

Randomized trial of thrombolysis versus heparin in unstable angina.

Schreiber TL, Rizik D, White C, Sharma GV, Cowley M, Macina G, Reddy PS, Kantounis L, Timmis GC, Margulis A, et al.

Circulation. 1992 Nov;86(5):1407-14.

PMID:
1423953
3.

Aspirin, heparin, or both to treat acute unstable angina.

Théroux P, Ouimet H, McCans J, Latour JG, Joly P, Lévy G, Pelletier E, Juneau M, Stasiak J, deGuise P, et al.

N Engl J Med. 1988 Oct 27;319(17):1105-11.

PMID:
3050522
4.

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia.

Gurfinkel EP, Manos EJ, Mejaíl RI, Cerdá MA, Duronto EA, García CN, Daroca AM, Mautner B.

J Am Coll Cardiol. 1995 Aug;26(2):313-8.

5.

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie AG, van der Meer J, Olaisson E, Undeland S, Ludwig K.

Circulation. 1997 Jul 1;96(1):61-8. Erratum in: Circulation 1998 Feb 3;97(4):413.

6.

Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.

Théroux P, Waters D, Qiu S, McCans J, de Guise P, Juneau M.

Circulation. 1993 Nov;88(5 Pt 1):2045-8.

PMID:
8222097
7.

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F.

N Engl J Med. 1997 Aug 14;337(7):447-52.

10.

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.

Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E.

Circulation. 1999 Oct 12;100(15):1593-601.

11.

Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.

Doucet S, Malekianpour M, Théroux P, Bilodeau L, Côté G, de Guise P, Dupuis J, Joyal M, Gosselin G, Tanguay JF, Juneau M, Harel F, Nattel S, Tardif JC, Lespérance J.

Circulation. 2000 Mar 7;101(9):955-61.

14.

Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.

Vejar M, Hackett D, Brunelli C, Spallarossa P, Ianetti M, Galassi AR, Lipkin D, Caponnetto S, Patrono C, Maseri A.

Circulation. 1990 Jan;81(1 Suppl):I4-11; discussion I22-3.

PMID:
2403867
16.

Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris.

Ardissino D, Barberis P, De Servi S, Mussini A, Rolla A, Visani L, Specchia G.

Am J Cardiol. 1990 Oct 15;66(12):910-4.

PMID:
2121016
17.

Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.

Schreiber TL, Macina G, McNulty A, Bunnell P, Kikel M, Miller DH, Devereux RB, Tenney R, Cowley M, Zola B.

Am J Cardiol. 1989 Oct 15;64(14):840-4.

PMID:
2801550
18.

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.

Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM, et al.

Circulation. 1995 Apr 1;91(7):1929-35.

19.
20.

Supplemental Content

Support Center